CCK as a modulator of cardiovascular function

Journal of Chemical Neuroanatomy

Volumn 38, Issue 3, 2009, Pages 176-184

  Lovick, Thelma A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cerebral blood flow; Environmental stress; Gastrointestinal hyperaemia; Neuropeptide modulation; Panic anxiety; Vagal reflex

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; PEPTIDE;

AMYGDALOID NUCLEUS; ANXIETY; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CHRONIC PAIN; DIGESTION; ENDOCRINE CELL; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; INTESTINE MOTILITY; INTESTINE SECRETION; INTESTINE WALL; LORDOSIS; MENTAL STRESS; MESENCEPHALON; NEUROMODULATION; NOCICEPTION; NONHUMAN; PANIC; PATHOPHYSIOLOGY; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; SATIETY; STIMULATION; STOMACH PROTECTION;

ANIMALS; AUTONOMIC PATHWAYS; BRAIN; CARDIOVASCULAR SYSTEM; CHOLECYSTOKININ; DIGESTION; GASTROINTESTINAL TRACT; HUMANS; NEUROTRANSMITTER AGENTS; REGIONAL BLOOD FLOW; STRESS, PHYSIOLOGICAL;

EID: 70349184802     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2009.06.007     Document Type: Review

References (114)

1. Abelson J.L., and Nesse R.M. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol. Psychiatry 36 (1994) 73-83
2. Abramov U., Raud S., Innos J., Lasner H., Kurrikoff K., Türna T., Puussaar T., Okva K., Matsui T., and Vasar E. Different housing conditions alter the behavioural phenotype of CCK(2) receptor-deficient mice. Behav. Brain Res. 193 1 (2008 Nov 3) 108-116
3. al Maskati H.A., and Zbrozyna A.W. Cardiovascular and motor components of the defence reaction elicited in rats by electrical and chemical stimulation in amygdala. J. Auton. Nerv. Syst. 28 (1989) 127-131
4. Andre J., Zeau B., Pohl M., Cesselin F., Benoliel J., and Becker C. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J. Neurosci. 25 (2005) 7896-7904
5. Atalay B., Bolay H., Dalkara T., Soylemezoglu F., Oge K., and Ozcan O.E. Transcorneal stimulation of trigeminal nerve afferents to increase cerebral blood flow in rats with cerebral vasospasm: a noninvasive method to activate the trigeminovascular reflex. J. Neurosurg. 97 (2002) 1179-1183
6. Baldwin B.A., Parrott R.F., and Ebenezer I.S. Food for thought: a critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor. Prog. Neurobiol. 55 (1998) 477-507
7. Ballaz S.J., Akil H., and Watson S.J. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence. Neurosci. Lett. 428 (2007) 27-32
8. Bandler R., and McCulloch T. Afferents to a midbrain periaqueductal grey region involved in the 'defense reaction' in the cat as revealed by horseradish peroxidase. II. The diencephalon. Behav. Brain Res. 13 (1984) 279-285
9. Baptista V., Browning K.N., and Travagli R.A. Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats. Am. J. Physiol. 292 (2007) R1092-R1100
10. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., and Benoliel J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol. Psychiatry 13 (2008) 1079-1092
11. Belelli D., Pistis M., Peters J.A., and Lambert J.J. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol. Sci. 20 (1999) 496-502
12. Benkelfat C., Bradwejn J., Meyer E., Ellenbogen M., Milot S., Gjedde A., and Evans A. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am. J. Psychiatry 152 (1995) 1180-1184
13. Berna M.J., Tapia J.A., Sancho V., and Jensen R.T. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. Curr. Opin. Pharmacol. 7 (2007) 583-592
14. Bertoglio L.J., and Zangrossi H. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Brain Res. 1059 (2005) 46-51
15. Billig I., Yates B.J., and Rinaman L. Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am. J. Physiol. Regul. Integr Comp. Physiol. 281 (2001) R1243-R1255
16. Blanchard D.C., Griebel G., and Blanchard R.J. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur. J. Pharmacol. 463 (2003) 97-116
17. Brack K.E., Jeffery S.M.T., and Lovick T.A. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle. Eur. J. Neurosci. 23 (2006) 3309-3318
18. Brack K.E., and Lovick T.A. Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats. Neuroscience 144 (2007) 325-335
19. Bradwejn J., Koszycki D., Annable L., Couëtoux du Tertre A., Reines S., and Karkanias C. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biol. Psychiatry 32 (1992) 903-912
20. Brzozowski T., Konturek P.C., Konturek S.J., Pajdo R., Drozdowicz D., Kwiecień S., and Hahn E.G. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul. Pept. 82 (1999) 19-33
21. Bunting M.W., Beart P.M., and Widdop R.E. Effects of the CCK(A) receptor antagonists SR 27897B and PD140548 on baroreflex function in conscious rats. Eur. J. Pharmacol. 337 (1997) 35-39
22. Calam J., Gordon D., Peart W.S., Taylor S.A., and Unwin R.J. Renal effects of gastrin C-terminal tetrapeptide (as pentagastrin) and cholecystokinin octapeptide in conscious rabbit and man. Br. J. Pharmacol. 91 (1987) 307-314
23. Cano V., Caicoya E., and Ruiz-Gayo M. Effect of peripheral cholecystokinin receptor agonists on c-Fos expression in brain sites mediating food consumption in rats. Neurosci. Lett. 343 (2003) 13-16
24. Carter D.A., and Lightman S.L. A role for the area postrema in mediating cholecystokinin-stimulated oxytocin secretion. Brain Res. 435 (1987) 327-330
25. Chandra R., and Liddle R.A. Cholecystokinin. Curr. Opin. Endocrinol. Diabetes Obes. 14 (2007) 63-67
26. Crawley J.N. Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?. Ann. N Y Acad. Sci. 448 (1985) 1-8
27. Davidowa H., Albrecht D., Gabriel H.J., Heublein S., and Wetzel K. Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors. Eur. J. Neurosci. 7 (1995) 2364-2369
28. de Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch. Gen. Psychiatry 46 (1989) 511-517
29. DSM IV, 1994. Diagnostic and Statistical Manual of Mental Disorders (1994) American Psychiatric Association.
30. Dufresne M., Seva C., and Fourmy D. Cholecystokinin and gastrin receptors. Physiol. Rev. 86 (2006) 805-847
31. Eckel L.A., Houpt T.A., and Geary N. Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R1378-R1385
32. Emson P.C., Lee C.M., and Rehfeld J.F. Cholecystokinin octapeptide: vesicular localization and calcium dependent release from rat brain in vitro. Life Sci. 26 (1980) 2157-2163
33. Eser D., Schüle C., Baghai T., Floesser A., Krebs-Brown A., Enunwa M., de la Motte S., Engel R., Kucher K., and Rupprecht R. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology (Berl) 192 (2007) 479-487
34. Evangelista S., and Maggi C.A. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibres and CCKA receptors. Br. J. Pharmacol. 102 (1991) 119-122
35. Fleet R.P., and Beitman B.D. Cardiovascular death from panic disorder and panic-like anxiety: a critical review of the literature. J. Psychosom. Res. 44 (1998) 71-80
36. Fossa A.A., DePasquale M.J., Morrone J., Zorn S.H., Bryce D., Lowe J.A., and McLean S. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog. J. Pharmacol. Exp. Ther. 281 (1997) 180-187
37. Freund T.F., Maglóczky Z., Soltész I., and Somogyi P. Synaptic connections, axonal and dendritic patterns of neurons immunoreactive for cholecystokinin in the visual cortex of the cat. Neuroscience 19 (1986) 1133-1159
38. Fry M., Hoyda T.D., and Ferguson A.V. Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis. Exp. Biol. Med. (Maywood) 232 (2007) 14-26
39. Gaw A.J., Hills D.M., and Spraggs C.F. Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat. Br. J. Pharmacol. 115 (1995) 660-664
40. Gieroba Z.J., and Blessing W.W. Vasopressin secretion after stimulation of abdominal vagus in rabbit: role of A1 norepinephrine neurons. Am. J. Physiol. 266 (1994) R1885-R1890
41. Gieroba Z.J., and Blessing W.W. Fos-containing neurons in medulla and pons after unilateral stimulation of the afferent abdominal vagus in conscious rabbits. Neuroscience 59 (1994) 851-858
42. Gieroba Z.J., Li Y.W., and Blessing W.W. Characteristics of caudal ventrolateral medullary neurons antidromically activated from rostral ventrolateral medulla in the rabbit. Brain Res. 582 (1992) 196-207
43. Griesbacher T., Rainer I., Heinemann A., and Groisman D. Haemodynamic and exocrine effects of caerulein at submaximal and supramaximal levels on the rat pancreas: role of cholecystokinin receptor subtypes. Pancreatology 6 (2006) 65-75
44. Gross P.M., Wall K.M., Pang J.J., Shaver S.W., and Wainman D.S. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol. 259 (1990) R1131-R1138
45. Guyenet P.G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7 (2006) 335-346
46. Haley G.E., and Flynn F.W. Tachykinin neurokinin 3 receptor signaling in cholecystokinin-elicited release of oxytocin and vasopressin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1760-R1767
47. Heinemann A., Jocic M., Peskar B.M., and Holzer P. CCK- evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am. J. Physiol. 270 (1996) G253-G258
48. Hendry S.H., Jones E.G., and Beinfeld M.C. Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 2400-2404
49. Hernandez-Gómez A.M., Aguilar-Roblero R., and Pérez de la Mora M. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety. Amino Acids 23 (2002) 283-290
50. Hilke S., Hökfelt T., Darwish M., and Theodorsson E. Cholecystokinin levels in the rat brain during the estrous cycle. Brain Res. 1144 (2007) 70-73
51. Hilton S.M., and Redfern W.S. A search for brain stem cell groups integrating the defence reaction in the rat. J. Physiol. 378 (1986) 213-228
52. Hilton S.M., and Zbrozyna A.W. Amygdaloid region for defence reactions and its efferent pathway to the brain stem. J. Physiol. 165 (1963) 160-173
53. Hösli E., and Hösli L. Binding of cholecystokinin, bombesin and muscarine to neurons and astrocytes in explant cultures of rat central nervous system: autoradiographic and immunohistochemical studies. Neuroscience 61 (1994) 63-72
54. Janssen P.J., Gardiner S.M., Compton A.M., and Bennett T. Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br. J. Pharmacol. 102 (1991) 123-134
55. Javanmard M., Shlik J., Kennedy S.H., Vaccarino F.J., Houle S., and Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol. Psychiatry 45 (1999) 872-882
56. Jerabek I., Boulenger J.P., Bradwejn J., Lavallée Y.J., and Jolicoeur F.B. CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. Eur. Neuropsychopharmacol. 9 (1999) 149-155
57. Khan S., Briggs H., and Abelson J.L. Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses. Psychiatry Res. 158 (2008) 141-146
58. Khan S., Liberzon I., and Abelson J.L. Effects of propranolol on symptom and endocrine responses to pentagastrin. Psychoneuroendocrinology 29 (2004) 1163-1171
59. Koszycki D., Zacharko R.M., Le Mellédo J.M., and Bradwejn J. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety 8 (1998) 1-7
60. Lader M., and Mathews A. Physiological changes during spontaneous panic attacks. J. Psychosom. Res. 14 (1970) 377-382
61. Le Mellédo J.M., Arthur H., Dalton J., Woo C., Lipton N., Bellavance F., Koszycki D., Boulenger J.P., and Bradwejn J. The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4. J. Psychosom. Res. 51 (2001) 513-520
62. Le Mellédo J.M., Merani S., Koszycki D., Bellavance F., Palmour R., Gutkowska J., Steinberg S., Bichet D.G., and Bradwejn J. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology 20 (1999) 81-91
63. Lines C., Challenor J., and Traub M. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. Br. J. Clin. Pharmacol. 39 (1995) 235-242
64. Liu-Chen L.Y., Norregaard T.V., and Moskowitz M.A. Some cholecystokinin-8 immunoreactive fibers in large pial arteries originate from trigeminal ganglion. Brain Res. 359 (1985) 166-176
65. Lovick T.A. Projections from the diencephalon and mesencephalon to nucleus paragigantocellularis lateralis in the cat. Neuroscience 14 (1985) 853-861
66. Lovick T.A. Projections from brainstem nuclei to the nucleus paragigantocellularis lateralis in the cat. J. Auton. Nerv. Syst. 16 (1986) 1-11
67. Lovick T.A. Differential control of cardiac and vasomotor activity by neurones in nucleus paragigantocellularis lateralis in the cat. J. Physiol. 389 (1987) 23-35
68. Lovick T.A. Midbrain and medullary regulation of defensive cardiovascular functions. Prog. Brain Res. 107 (1996) 301-313
69. Lovick T.A. Panic disorder-a malfunction of multiple transmitter control systems within the periaqueductal gray matter?. Neuroscientist 6 (2000) 48-49
70. Lovick T.A. CCK2 receptor-immunoreactive neurones in the periaqueductal gray matter of male and female rats: relationship to GABAergic neurones. Soc. Neurosci. abst. (2007) 37 921.18
71. Lovick T.A. Pro-nociceptive action of cholecystokinin in the periaqueductal grey: a role in neuropathic and anxiety-induced hyperalgesic states. Neurosci. Biobehav. Rev. 32 (2008) 852-862
72. Luo B., Cheu J.W., and Siegel A. Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat. Brain Res. 796 (1998) 27-37
73. Maolood N., and Meister B. Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region. J. Chem. Neuroanat. 37 (2009) 182-195
74. Mantyh P.W. Forebrain projections to the periaqueductal gray in the monkey, with observations in the cat and rat. J. Comp. Neurol. 206 (1982) 146-158
75. Mercer L.D., and Beart P.M. Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor. Neurosci. Lett. 225 (1997) 97-100
76. Mercer L.D., Le V.Q., Nunan J., Jones N.M., and Beart P.M. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci Lett. 293 (2000) 167-170
77. Micevych P., and Sinchak K. Estrogen and endogenous opioids regulate CCK in reproductive circuits. Peptides 22 (2001) 1235-1244
78. Mobley S.C., Mandel D.A., and Schreihofer A.M. Systemic cholecystokinin differentially affects baro-activated GABAergic neurons in rat caudal ventrolateral medulla. J. Neurophysiol. 96 (2006) 2760-2768
79. Munro G., Pumford K.M., and Russell J.A. Altered cholecystokinin binding site density in the supraoptic nucleus of morphine-tolerant and -dependent rats. Brain Res. 780 (1998) 190-198
80. Müller W., Heinemann U., and Berlin K. Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes. J. Neurophysiol. 78 (1997) 1997-2001
81. Netto C.F., and Guimarães F.S. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray. Neuropsychopharmacology 29 (2004) 101-107
82. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781
83. Obara H., Kusunoki M., Morim M., Mikawa K., and Iwai S. The effects of various peptides on the isolated pulmonary artery. Peptides 10 (1989) 241-323
84. O'Connor T.P., and van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J. Neurosci. 8 (1988) 2468-2476
85. Peitl B., Németh J., Szolcsányi J., Szilvássy Z., and Pórszász R. Sensory nitrergic meningeal vasodilatation and non-nitrergic plasma extravasation in anaesthesized rats. Eur. J. Pharmacol. 497 (2004) 293-299
86. Pérez de la Mora M., Hernández-Gómez A.M., Arizmendi-García Y., Jacobsen K.X., Lara-García D., Flores-Gracia C., Crespo-Ramírez M., Gallegos-Cari A., Nuche-Bricaire A., and Fuxe K. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release. Eur. J. Neurosci. 26 (2007) 3614-3630
87. Premen A.J., Soika C.Y., Dabney J.M., and Dobbins D.E. Effects of gastrointestinal hormones on ileal vascular and visceral smooth muscle. Am. J. Physiol. 246 (1984) G1-G7
88. Reeve J.R., Eysselein V.E., Walsh J.H., Sankaran H., Deveney C.W., Tourtellotte W.W., Miller C., and Shively J.E. Isolation and characterization of biologically active and inactive cholecystokinin-octapeptides from human brain. Peptides 5 (1984) 959-966
89. Reeve J.R., Green G.M., Chew P., Eysselein V.E., and Keire D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G255-G265
90. Rehfeld J.F. Neuronal cholecystokinin: one or multiple transmitters?. J. Neurochem. 44 (1985) 1-10
91. Rehfeld J.F., Friis-Hansen L., Goetze J.P., and Hansen T.V.O. The biology of cholecystokinin and gastrin peptides. Curr. Top. Med. Chem. 7 (2007) 1154-1165
92. Rex A., Barth T., Voigt J.P., Domeney A.M., and Fink H. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci. Lett. 172 (1994) 139-142
93. Ruiz-Gayo M., González M.C., and Fernández-Alfonso S. Vasodilatory effects of cholecystokinin: new role for an old peptide?. Regul. Pept. 137 (2006) 179-184
94. Sánchez-Fernández C., González M.C., Beart P.M., Mercer L.D., Ruiz-Gayo M., and Fernández-Alfonso M.S. A novel role for cholecystokinin: regulation of mesenteric vascular resistance. Regul. Pept. 121 (2004) 145-153
95. Sánchez-Fernández C., González C., Mercer L.D., Beart P.M., Ruiz-Gayo M., and Fernández-Alfonso M.S. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic. J. Cereb. Blood Flow Metab. 23 (2003) 364-370
96. Sartor D.M., and Verberne A.J.M. Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R1174-R1184
97. Sartor D.M., and Verberne A.J.M. Phenotypic identification of rat rostroventrolateral medullary presympathetic vasomotor neurons inhibited by exogenous cholecystokinin. J. Comp. Neurol. 465 (2003) 467-479
98. Sartor D.M., and Verberne A.J.M. The sympathoinhibitory effects of systemic cholecystokinin are dependent on neurons in the caudal ventrolateral medulla in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R1390-R1398
99. Sartor D.M., and Verberne A.J.M. Abdominal vagal signalling: a novel role for cholecystokinin in circulatory control?. Brain Res. Rev. 59 (2008) 140-154
100. Sayegh A.I., and Ritter R.C. Vagus nerve participates in CCK-induced Fos expression in hindbrain but not myenteric plexus. Brain Res. 878 (2000) 155-162
101. Sayegh A.I., and Ritter R.C. Cholecystokinin activates specific enteric neurons in the rat small intestine. Peptides 24 (2003) 237-244
102. Schenberg L.C., Bittencourt A.S., Sudré E.C., and Vargas L.C. Modeling panic attacks. Neurosci. Biobehav. Rev. 25 (2001) 647-659
103. Singewald N., and Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98 (2000) 759-770
104. Takano T., Tian G., Peng W., Lou N., Libionka W., Han X., and Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9 (2006) 260-267
105. Van Dijk A., Richards J.G., Trzeciak A., Gillessen D., and Möhler H. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand. J. Neurosci. 4 (1984) 1021-1033
106. van Megen H.J., Westenberg H.G., den Boer J.A., Slaap B., van Es-Radhakishun F., and Pande A.C. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients. Psychopharmacology (Berl) 129 (1997) 243-248
107. Verberne A.J.M., and Sartor D.M. CCK-induced inhibition of presympathetic vasomotor neurons: dependence on subdiaphragmatic vagal afferents and central NMDA receptors in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R809-R816
108. Wang H., Wong P.T., Spiess J., and Zhu Y.Z. Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats. Neurosci. Biobehav. Rev. 29 (2005) 1361-1373
109. Watanabe S., Kunitake T., Kato K., Chu C., Nakao H., Qiu D., and Kannan H. Single-unit activity of paraventricular nucleus neurons in response to intero- and exteroceptive stressors in conscious, freely moving rats. Brain Res. 995 (2004) 97-108
110. Webb J.K., Rupniak N.M., and Boyce S. Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide. Regul. Pept. 61 (1996) 71-76
111. Wisniewska R.J., and Wiśniewski K. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats. Gen. Pharmacol. 27 (1996) 159-163
112. Yardley C.P., and Hilton S.M. The hypothalamic and brainstem areas from which the cardiovascular and behavioural components of the defence reaction are elicited in the rat. J. Auton. Nerv. Syst. 15 (1986) 227-244
113. Zhu X.G., Greeley G.H., Lewis B.G., Lilja P., and Thompson J.C. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. J. Neurosci. Res. 15 (1986) 393-403
114. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K., Pozzan T., and Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6 (2003) 43-50